Globus Medical
GMED
253 hedge funds and large institutions have $2.04B invested in Globus Medical in 2017 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 99 increasing their positions, 77 reducing their positions, and 26 closing their positions.
1,618% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $722K
50% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 26
29% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 77
6.74% more ownership
Funds ownership: 88.54% → 95.28% (+6.7%)
4% more funds holding
Funds holding: 244 → 253 (+9)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $2.11B → $2.04B (-$69.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$44.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$29.9M |
| 3 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$26.6M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$24.8M |
| 5 |
Renaissance Technologies
New York
|
+$18.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$69.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.6M |
| 3 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$11.6M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$7.62M |
| 5 |
Bank of New York Mellon
New York
|
-$7.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCM
276
McKinley Capital Management
Anchorage,
Alaska
| – | -$11K | -340 | Closed |
|
277
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$5K | -154 | Closed |
|
|
WA
278
Winfield Associates
Cleveland,
Ohio
| – | -$4K | -120 | Closed |
|
|
IUHSA
279
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
| – | -$1K | -40 | Closed |
|
GMED Hedge Fund Activity: Q3 2017 in Review
253 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2017, worth a combined $2.04B — down 3.3% from $2.11B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new GMED positions and 26 closed out — a net gain of 13 holders — while 99 added to existing stakes and 77 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $44.3M. The largest seller was Consonance Capital Management, cutting an estimated $69.6M.
- 253 institutional investors held Globus Medical (GMED) as of Q3 2017, up from 244 in Q2 2017.
- Funds reported $2.04B of Globus Medical stock for Q3 2017, down 3.3% quarter-over-quarter.
- 39 funds opened new Globus Medical positions in Q3 2017 and 26 closed out, a net change of +13 holders.
- The largest Globus Medical buyer in Q3 2017 was Wellington Management Group, an estimated $44.3M added.
- The largest Globus Medical seller in Q3 2017 was Consonance Capital Management, an estimated $69.6M sold.
Based on aggregated 13F filings for Q3 2017.